Abbott receives ce mark for its volt™ pulsed field ablation system to treat patients with abnormal heart rhythms

Abbott's volt™ pfa system is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation pulsed field ablation – or pfa – uses high energy electrical pulses for ablation procedures that may offer benefits to targeting and treating tissue in the heart abbott's volt pfa system is designed to overcome limitations of existing pfa systems, providing improved workflows and a clearer indication of contact between the volt pfa catheter and targeted tissue abbott park, ill., march 27, 2025 /prnewswire/ -- abbott (nyse: abt) today announced it has received ce mark in europe for the volt™ pfa system to treat patients battling atrial fibrillation (afib).
ABT Ratings Summary
ABT Quant Ranking